Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
According to the latest documents submitted to the U.S. Securities and Exchange Commission (SEC), biopharmaceutical company Spruce Biosciences, Inc. has been authorized to offer and sell its common stock under the current sales agreement, with the total amount not exceeding the planned maximum limit.

According to the latest documents submitted to the U.S. Securities and Exchange Commission (SEC), biopharmaceutical company Spruce Biosciences, Inc. has been authorized to offer and sell its common stock under the current sales agreement, with the total amount not exceeding the planned maximum limit.

老虎证券老虎证券2026/03/09 11:47
Show original
This arrangement provides the company with a flexible financing channel, enabling it to issue shares on the open market in a timely manner according to market conditions and capital needs. This filing clarifies the company's potential future equity financing activities, but the specific timing, quantity, and price of the issuance will depend on actual circumstances.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!